ID   DRD2_RAT                Reviewed;         444 AA.
AC   P61169; P13953;
DT   10-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2004, sequence version 1.
DT   02-OCT-2024, entry version 174.
DE   RecName: Full=D(2) dopamine receptor;
DE   AltName: Full=Dopamine D2 receptor;
GN   Name=Drd2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
RC   TISSUE=Brain;
RX   PubMed=2974511; DOI=10.1038/336783a0;
RA   Bunzow J.R., van Tol H.H.M., Grandy D.K., Albert P., Salon J., Christie M.,
RA   Machida C.A., Neve K.A., Civelli O.;
RT   "Cloning and expression of a rat D2 dopamine receptor cDNA.";
RL   Nature 336:783-787(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG), AND TISSUE SPECIFICITY.
RX   PubMed=2531656; DOI=10.1002/j.1460-2075.1989.tb08585.x;
RA   Dal-Toso R., Sommer B., Ewert M., Herb A., Pritchett D.B., Bach A.,
RA   Shivers B.D., Seeburg P.H.;
RT   "The dopamine D2 receptor: two molecular forms generated by alternative
RT   splicing.";
RL   EMBO J. 8:4025-4034(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2531846; DOI=10.1038/342865a0;
RA   Eidne K.A., Taylor P.L., Zabavnik J., Saunders P.T.K., Inglis J.D.;
RT   "D2 receptor, a missing exon.";
RL   Nature 342:865-865(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2531847; DOI=10.1038/342923a0;
RA   Giros B., Sokoloff P., Martres M.-P., Riou J.-F., Emorine L.J.,
RA   Schwartz J.-C.;
RT   "Alternative splicing directs the expression of two D2 dopamine receptor
RT   isoforms.";
RL   Nature 342:923-926(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2480527; DOI=10.1038/342926a0;
RA   Monsma F.J. Jr., McVittie L.D., Gerfen C.R., Mahan L.C., Sibley D.R.;
RT   "Multiple D2 dopamine receptors produced by alternative RNA splicing.";
RL   Nature 342:926-929(1989).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2139615; DOI=10.1016/0014-5793(90)80695-f;
RA   Rao D.D., McKelvy J., Kebabian J., MacKenzie R.G.;
RT   "Two forms of the rat D2 dopamine receptor as revealed by the polymerase
RT   chain reaction.";
RL   FEBS Lett. 263:18-22(1990).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
RC   STRAIN=Sprague-Dawley;
RA   Taylor P.L., Inglis J.D., Eidne K.A.;
RT   "5'untranslated region of rat pituitary dopamine D2(B) receptor contains a
RT   putative CpG island.";
RL   Submitted (OCT-1990) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 242-270.
RX   PubMed=2137336; DOI=10.1016/0006-291x(90)91917-h;
RA   Miller J.C., Wang Y., Filer D.;
RT   "Identification by sequence analysis of a second rat brain cDNA encoding
RT   the dopamine (D2) receptor.";
RL   Biochem. Biophys. Res. Commun. 166:109-112(1990).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 242-270.
RX   PubMed=2138567; DOI=10.1016/0014-5793(90)80140-e;
RA   O'Dowd B.F., Nguyen T., Tirpak A., Jarvie K.R., Israel Y., Seeman P.,
RA   Niznik H.B.;
RT   "Cloning of two additional catecholamine receptors from rat brain.";
RL   FEBS Lett. 262:8-12(1990).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG), AND TISSUE SPECIFICITY.
RX   PubMed=2137198; DOI=10.1038/343266a0;
RA   Chio C.L., Hess G.F., Graham R.S., Huff R.M.;
RT   "A second molecular form of D2 dopamine receptor in rat and bovine caudate
RT   nucleus.";
RL   Nature 343:266-269(1990).
RN   [11]
RP   FUNCTION, AND MUTAGENESIS OF SER-193; SER-194; SER-197 AND SER-420.
RX   PubMed=1321233; DOI=10.1111/j.1471-4159.1992.tb09416.x;
RA   Cox B.A., Henningsen R.A., Spanoyannis A., Neve R.L., Neve K.A.;
RT   "Contributions of conserved serine residues to the interactions of ligands
RT   with dopamine D2 receptors.";
RL   J. Neurochem. 59:627-635(1992).
RN   [12]
RP   INTERACTION WITH PPP1R9B.
RX   PubMed=10391935; DOI=10.1074/jbc.274.28.19894;
RA   Smith F.D., Oxford G.S., Milgram S.L.;
RT   "Association of the D2 dopamine receptor third cytoplasmic loop with
RT   spinophilin, a protein phosphatase-1-interacting protein.";
RL   J. Biol. Chem. 274:19894-19900(1999).
RN   [13]
RP   INTERACTION WITH CLIC6.
RX   PubMed=14499480; DOI=10.1016/s0169-328x(03)00283-3;
RA   Griffon N., Jeanneteau F., Prieur F., Diaz J., Sokoloff P.;
RT   "CLIC6, a member of the intracellular chloride channel family, interacts
RT   with dopamine D(2)-like receptors.";
RL   Brain Res. Mol. Brain Res. 117:47-57(2003).
RN   [14]
RP   INTERACTION WITH GPRASP1.
RX   PubMed=16049099; DOI=10.1073/pnas.0502418102;
RA   Bartlett S.E., Enquist J., Hopf F.W., Lee J.H., Gladher F., Kharazia V.,
RA   Waldhoer M., Mailliard W.S., Armstrong R., Bonci A., Whistler J.L.;
RT   "Dopamine responsiveness is regulated by targeted sorting of D2
RT   receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:11521-11526(2005).
RN   [15]
RP   INTERACTION WITH ARRB2.
RX   PubMed=19332542; DOI=10.1074/jbc.m900388200;
RA   Namkung Y., Dipace C., Javitch J.A., Sibley D.R.;
RT   "G protein-coupled receptor kinase-mediated phosphorylation regulates post-
RT   endocytic trafficking of the D2 dopamine receptor.";
RL   J. Biol. Chem. 284:15038-15051(2009).
RN   [16]
RP   3D-STRUCTURE MODELING.
RX   PubMed=1358063; DOI=10.1042/bj2870277;
RA   Livingstone C.D., Strange P.G., Naylor L.H.;
RT   "Molecular modelling of D2-like dopamine receptors.";
RL   Biochem. J. 287:277-282(1992).
CC   -!- FUNCTION: Dopamine receptor whose activity is mediated by G proteins
CC       which inhibit adenylyl cyclase (PubMed:1321233). Positively regulates
CC       postnatal regression of retinal hyaloid vessels via suppression of
CC       VEGFR2/KDR activity, downstream of OPN5 (By similarity).
CC       {ECO:0000250|UniProtKB:P61168, ECO:0000269|PubMed:1321233}.
CC   -!- SUBUNIT: Forms homo- and heterooligomers with DRD4 (By similarity). The
CC       interaction with DRD4 may modulate agonist-induced downstream signaling
CC       (By similarity). Interacts with CADPS and CADPS2 (By similarity).
CC       Interacts with GPRASP1, PPP1R9B and CLIC6 (PubMed:10391935,
CC       PubMed:14499480, PubMed:16049099). Interacts with ARRB2
CC       (PubMed:19332542). Interacts with HTR2A (By similarity). Interacts with
CC       DRD1 (By similarity). Interacts with KCNA2 (By similarity).
CC       {ECO:0000250|UniProtKB:P14416, ECO:0000250|UniProtKB:P61168}.
CC   -!- INTERACTION:
CC       P61169; O35274: Ppp1r9b; NbExp=2; IntAct=EBI-80012, EBI-80022;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P14416};
CC       Multi-pass membrane protein {ECO:0000255}. Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:P14416}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long; Synonyms=D2A, D2in;
CC         IsoId=P61169-1, P13953-1;
CC         Sequence=Displayed;
CC       Name=Short; Synonyms=D2B, D2o;
CC         IsoId=P61169-2, P13953-2;
CC         Sequence=VSP_001871;
CC   -!- TISSUE SPECIFICITY: [Isoform Long]: Expressed in the anterior lobe of
CC       the pituitary gland (PubMed:2531656). Expressed ventral tegmental area
CC       of the midbrain and the pars compacta of the substantia nigra
CC       (PubMed:2531656). Expressed seven times more than isoform short in the
CC       caudate nucleus (PubMed:2137198). {ECO:0000269|PubMed:2137198,
CC       ECO:0000269|PubMed:2531656}.
CC   -!- TISSUE SPECIFICITY: [Isoform Short]: Expressed in the anterior lobe of
CC       the pituitary gland (PubMed:2531656). Expressed in the caudate nucleus
CC       (PubMed:2137198). Not expressed in the wider brain (PubMed:2531656).
CC       {ECO:0000269|PubMed:2137198, ECO:0000269|PubMed:2531656}.
CC   -!- PTM: Palmitoylated. Palmitoylation which is required for proper
CC       localization to the plasma membrane and stability of the receptor could
CC       be carried on by ZDHHC4, ZDHHC3 and ZDHHC8.
CC       {ECO:0000250|UniProtKB:P14416}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M36831; AAA41075.1; -; mRNA.
DR   EMBL; X53278; CAA37373.1; -; mRNA.
DR   EMBL; X56065; CAA39543.1; -; mRNA.
DR   EMBL; M32241; AAA41074.1; -; mRNA.
DR   PIR; S08146; S08146.
DR   RefSeq; NP_036679.1; NM_012547.1. [P61169-1]
DR   RefSeq; XP_006243041.1; XM_006242979.3.
DR   AlphaFoldDB; P61169; -.
DR   SMR; P61169; -.
DR   BioGRID; 246498; 11.
DR   CORUM; P61169; -.
DR   DIP; DIP-30883N; -.
DR   IntAct; P61169; 5.
DR   MINT; P61169; -.
DR   STRING; 10116.ENSRNOP00000043759; -.
DR   BindingDB; P61169; -.
DR   ChEMBL; CHEMBL339; -.
DR   DrugCentral; P61169; -.
DR   GuidetoPHARMACOLOGY; 215; -.
DR   GlyCosmos; P61169; 3 sites, No reported glycans.
DR   GlyGen; P61169; 3 sites.
DR   iPTMnet; P61169; -.
DR   MetOSite; P61169; -.
DR   PhosphoSitePlus; P61169; -.
DR   PaxDb; 10116-ENSRNOP00000043759; -.
DR   ABCD; P61169; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000045944.6; ENSRNOP00000043759.4; ENSRNOG00000008428.8. [P61169-1]
DR   Ensembl; ENSRNOT00000083419.2; ENSRNOP00000074235.1; ENSRNOG00000008428.8. [P61169-2]
DR   Ensembl; ENSRNOT00055047800; ENSRNOP00055039344; ENSRNOG00055027586. [P61169-1]
DR   Ensembl; ENSRNOT00060028512; ENSRNOP00060022946; ENSRNOG00060016643. [P61169-1]
DR   Ensembl; ENSRNOT00065031576; ENSRNOP00065025170; ENSRNOG00065018800. [P61169-1]
DR   GeneID; 24318; -.
DR   KEGG; rno:24318; -.
DR   UCSC; RGD:2520; rat.
DR   AGR; RGD:2520; -.
DR   CTD; 1813; -.
DR   RGD; 2520; Drd2.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT00940000155539; -.
DR   InParanoid; P61169; -.
DR   OMA; APMDPLN; -.
DR   OrthoDB; 2999405at2759; -.
DR   PhylomeDB; P61169; -.
DR   TreeFam; TF334382; -.
DR   Reactome; R-RNO-390651; Dopamine receptors.
DR   PRO; PR:P61169; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Bgee; ENSRNOG00000008428; Expressed in cerebellum and 1 other cell type or tissue.
DR   GO; GO:0001669; C:acrosomal vesicle; IDA:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0060170; C:ciliary membrane; ISO:RGD.
DR   GO; GO:0005929; C:cilium; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0098691; C:dopaminergic synapse; ISO:RGD.
DR   GO; GO:0030139; C:endocytic vesicle; IDA:RGD.
DR   GO; GO:0097648; C:G protein-coupled receptor complex; ISO:RGD.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016328; C:lateral plasma membrane; IDA:RGD.
DR   GO; GO:0016020; C:membrane; IDA:BHF-UCL.
DR   GO; GO:0097730; C:non-motile cilium; ISO:RGD.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; ISO:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0036126; C:sperm flagellum; IDA:RGD.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IDA:RGD.
DR   GO; GO:0035240; F:dopamine binding; IMP:RGD.
DR   GO; GO:0004952; F:dopamine neurotransmitter receptor activity; ISO:RGD.
DR   GO; GO:0001591; F:dopamine neurotransmitter receptor activity, coupled via Gi/Go; IDA:BHF-UCL.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; ISO:RGD.
DR   GO; GO:0001965; F:G-protein alpha-subunit binding; ISO:RGD.
DR   GO; GO:1901363; F:heterocyclic compound binding; IPI:RGD.
DR   GO; GO:0032795; F:heterotrimeric G-protein binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0035255; F:ionotropic glutamate receptor binding; IPI:RGD.
DR   GO; GO:0097159; F:organic cyclic compound binding; IPI:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:RGD.
DR   GO; GO:0046717; P:acid secretion; IDA:BHF-UCL.
DR   GO; GO:0021984; P:adenohypophysis development; ISO:RGD.
DR   GO; GO:0071880; P:adenylate cyclase-activating adrenergic receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007195; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; IDA:RGD.
DR   GO; GO:0030534; P:adult behavior; ISO:RGD.
DR   GO; GO:0007628; P:adult walking behavior; ISO:RGD.
DR   GO; GO:0050482; P:arachidonic acid secretion; ISO:RGD.
DR   GO; GO:0008306; P:associative learning; ISO:RGD.
DR   GO; GO:0031223; P:auditory behavior; IMP:RGD.
DR   GO; GO:0006914; P:autophagy; IDA:RGD.
DR   GO; GO:0007409; P:axonogenesis; ISO:RGD.
DR   GO; GO:0048148; P:behavioral response to cocaine; ISO:RGD.
DR   GO; GO:0048149; P:behavioral response to ethanol; ISO:RGD.
DR   GO; GO:0048755; P:branching morphogenesis of a nerve; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0071361; P:cellular response to ethanol; IEP:RGD.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEP:RGD.
DR   GO; GO:0021853; P:cerebral cortex GABAergic interneuron migration; ISO:RGD.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISO:RGD.
DR   GO; GO:0042417; P:dopamine metabolic process; ISO:RGD.
DR   GO; GO:0051583; P:dopamine uptake involved in synaptic transmission; ISO:RGD.
DR   GO; GO:0042756; P:drinking behavior; IDA:RGD.
DR   GO; GO:0050673; P:epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0007631; P:feeding behavior; ISO:RGD.
DR   GO; GO:0030900; P:forebrain development; IMP:RGD.
DR   GO; GO:0007212; P:G protein-coupled dopamine receptor signaling pathway; IDA:RGD.
DR   GO; GO:0002031; P:G protein-coupled receptor internalization; IDA:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007625; P:grooming behavior; ISO:RGD.
DR   GO; GO:1990384; P:hyaloid vascular plexus regression; ISS:UniProtKB.
DR   GO; GO:0030007; P:intracellular potassium ion homeostasis; IC:BHF-UCL.
DR   GO; GO:0035556; P:intracellular signal transduction; ISO:RGD.
DR   GO; GO:0007626; P:locomotory behavior; IMP:RGD.
DR   GO; GO:0007616; P:long-term memory; IMP:RGD.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0045776; P:negative regulation of blood pressure; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:1900038; P:negative regulation of cellular response to hypoxia; IMP:RGD.
DR   GO; GO:0042321; P:negative regulation of circadian sleep/wake cycle, sleep; IDA:RGD.
DR   GO; GO:0051481; P:negative regulation of cytosolic calcium ion concentration; IMP:RGD.
DR   GO; GO:0060160; P:negative regulation of dopamine receptor signaling pathway; ISO:RGD.
DR   GO; GO:0033602; P:negative regulation of dopamine secretion; IMP:RGD.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0045824; P:negative regulation of innate immune response; ISO:RGD.
DR   GO; GO:0046676; P:negative regulation of insulin secretion; IMP:RGD.
DR   GO; GO:2001223; P:negative regulation of neuron migration; ISO:RGD.
DR   GO; GO:0051898; P:negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IMP:RGD.
DR   GO; GO:0050709; P:negative regulation of protein secretion; ISO:RGD.
DR   GO; GO:0050805; P:negative regulation of synaptic transmission; IDA:RGD.
DR   GO; GO:0051967; P:negative regulation of synaptic transmission, glutamatergic; ISO:RGD.
DR   GO; GO:1901386; P:negative regulation of voltage-gated calcium channel activity; IDA:BHF-UCL.
DR   GO; GO:0001976; P:nervous system process involved in regulation of systemic arterial blood pressure; ISO:RGD.
DR   GO; GO:0007405; P:neuroblast proliferation; ISO:RGD.
DR   GO; GO:0001764; P:neuron migration; ISO:RGD.
DR   GO; GO:0007270; P:neuron-neuron synaptic transmission; ISO:RGD.
DR   GO; GO:0021769; P:orbitofrontal cortex development; IEP:RGD.
DR   GO; GO:0030432; P:peristalsis; ISO:RGD.
DR   GO; GO:0043491; P:phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0060158; P:phospholipase C-activating dopamine receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0043473; P:pigmentation; ISO:RGD.
DR   GO; GO:0032467; P:positive regulation of cytokinesis; ISO:RGD.
DR   GO; GO:0051586; P:positive regulation of dopamine uptake involved in synaptic transmission; ISO:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:RGD.
DR   GO; GO:0045745; P:positive regulation of G protein-coupled receptor signaling pathway; IMP:RGD.
DR   GO; GO:1900168; P:positive regulation of glial cell-derived neurotrophic factor production; ISO:RGD.
DR   GO; GO:0060124; P:positive regulation of growth hormone secretion; ISO:RGD.
DR   GO; GO:1900273; P:positive regulation of long-term synaptic potentiation; IMP:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IBA:GO_Central.
DR   GO; GO:0045840; P:positive regulation of mitotic nuclear division; TAS:BHF-UCL.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; ISO:RGD.
DR   GO; GO:0002052; P:positive regulation of neuroblast proliferation; ISO:RGD.
DR   GO; GO:0050769; P:positive regulation of neurogenesis; IDA:RGD.
DR   GO; GO:0002092; P:positive regulation of receptor internalization; IMP:RGD.
DR   GO; GO:0035815; P:positive regulation of renal sodium excretion; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:RGD.
DR   GO; GO:0035810; P:positive regulation of urine volume; ISO:RGD.
DR   GO; GO:0099170; P:postsynaptic modulation of chemical synaptic transmission; IDA:SynGO.
DR   GO; GO:0060134; P:prepulse inhibition; ISO:RGD.
DR   GO; GO:0099171; P:presynaptic modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0008104; P:protein localization; ISO:RGD.
DR   GO; GO:0014059; P:regulation of dopamine secretion; IBA:GO_Central.
DR   GO; GO:0051584; P:regulation of dopamine uptake involved in synaptic transmission; ISO:RGD.
DR   GO; GO:0002027; P:regulation of heart rate; ISO:RGD.
DR   GO; GO:0090325; P:regulation of locomotion involved in locomotory behavior; IMP:RGD.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; ISO:RGD.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IDA:RGD.
DR   GO; GO:0051580; P:regulation of neurotransmitter uptake; ISO:RGD.
DR   GO; GO:0043266; P:regulation of potassium ion transport; IDA:BHF-UCL.
DR   GO; GO:0002028; P:regulation of sodium ion transport; ISO:RGD.
DR   GO; GO:0051823; P:regulation of synapse structural plasticity; IDA:RGD.
DR   GO; GO:0032228; P:regulation of synaptic transmission, GABAergic; ISO:RGD.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IMP:BHF-UCL.
DR   GO; GO:0001975; P:response to amphetamine; IEP:RGD.
DR   GO; GO:0048678; P:response to axon injury; IEP:RGD.
DR   GO; GO:0042220; P:response to cocaine; ISO:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0034776; P:response to histamine; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IMP:RGD.
DR   GO; GO:0014854; P:response to inactivity; IEP:RGD.
DR   GO; GO:0010039; P:response to iron ion; IEP:RGD.
DR   GO; GO:0009416; P:response to light stimulus; ISO:RGD.
DR   GO; GO:0043278; P:response to morphine; ISO:RGD.
DR   GO; GO:0035094; P:response to nicotine; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IDA:BHF-UCL.
DR   GO; GO:0007608; P:sensory perception of smell; ISO:RGD.
DR   GO; GO:0001964; P:startle response; ISO:RGD.
DR   GO; GO:0021756; P:striatum development; IEP:RGD.
DR   GO; GO:0007416; P:synapse assembly; IEP:BHF-UCL.
DR   GO; GO:0001659; P:temperature homeostasis; ISO:RGD.
DR   GO; GO:0008542; P:visual learning; ISO:RGD.
DR   GO; GO:0016055; P:Wnt signaling pathway; IDA:RGD.
DR   CDD; cd15309; 7tmA_D2_dopamine_R; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 2.
DR   InterPro; IPR001922; Dopamine_D2_rcpt.
DR   InterPro; IPR000929; Dopamine_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR24248; ADRENERGIC RECEPTOR-RELATED G-PROTEIN COUPLED RECEPTOR; 1.
DR   PANTHER; PTHR24248:SF87; D(2) DOPAMINE RECEPTOR; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00567; DOPAMINED2R.
DR   PRINTS; PR00242; DOPAMINER.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Golgi apparatus; Lipoprotein;
KW   Membrane; Palmitate; Receptor; Reference proteome; Transducer;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..444
FT                   /note="D(2) dopamine receptor"
FT                   /id="PRO_0000069390"
FT   TOPO_DOM        1..37
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        38..60
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        61..70
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        71..93
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        94..108
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        109..130
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        131..151
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        152..172
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        173..188
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        189..213
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        214..374
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        375..396
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        397..410
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        411..432
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        433..444
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   REGION          211..374
FT                   /note="Interaction with PPP1R9B"
FT                   /evidence="ECO:0000269|PubMed:10391935"
FT   REGION          282..329
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            194
FT                   /note="Important for receptor activation"
FT   SITE            197
FT                   /note="Important for receptor activation"
FT   LIPID           444
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P14416"
FT   CARBOHYD        5
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        17
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        23
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        107..182
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   DISULFID        400..402
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   VAR_SEQ         242..270
FT                   /note="Missing (in isoform Short)"
FT                   /evidence="ECO:0000303|PubMed:2974511"
FT                   /id="VSP_001871"
FT   MUTAGEN         193
FT                   /note="S->A: Moderate decrease in ligand binding. 200-fold
FT                   reduction of agonist-mediated cAMP inhibition."
FT                   /evidence="ECO:0000269|PubMed:1321233"
FT   MUTAGEN         194
FT                   /note="S->A: Small decrease in agonist binding. Complete
FT                   loss of agonist-mediated cAMP inhibition."
FT                   /evidence="ECO:0000269|PubMed:1321233"
FT   MUTAGEN         197
FT                   /note="S->A: Small decrease in agonist binding. 18-fold
FT                   reduction of agonist-mediated cAMP inhibition."
FT                   /evidence="ECO:0000269|PubMed:1321233"
FT   MUTAGEN         420
FT                   /note="S->A: Moderate decrease in ligand binding."
FT                   /evidence="ECO:0000269|PubMed:1321233"
FT   CONFLICT        99
FT                   /note="E -> D (in Ref. 6; CAA37373)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        173
FT                   /note="G -> R (in Ref. 6; CAA37373)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        180
FT                   /note="N -> G (in Ref. 6; CAA37373)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   444 AA;  50904 MW;  216E56CEE5CA32FB CRC64;
     MDPLNLSWYD DDLERQNWSR PFNGSEGKAD RPHYNYYAML LTLLIFIIVF GNVLVCMAVS
     REKALQTTTN YLIVSLAVAD LLVATLVMPW VVYLEVVGEW KFSRIHCDIF VTLDVMMCTA
     SILNLCAISI DRYTAVAMPM LYNTRYSSKR RVTVMIAIVW VLSFTISCPL LFGLNNTDQN
     ECIIANPAFV VYSSIVSFYV PFIVTLLVYI KIYIVLRKRR KRVNTKRSSR AFRANLKTPL
     KGNCTHPEDM KLCTVIMKSN GSFPVNRRRM DAARRAQELE MEMLSSTSPP ERTRYSPIPP
     SHHQLTLPDP SHHGLHSNPD SPAKPEKNGH AKIVNPRIAK FFEIQTMPNG KTRTSLKTMS
     RRKLSQQKEK KATQMLAIVL GVFIICWLPF FITHILNIHC DCNIPPVLYS AFTWLGYVNS
     AVNPIIYTTF NIEFRKAFMK ILHC
//
